BOT 2.78% 35.0¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-36

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,544 Posts.
    lightbulb Created with Sketch. 318
    Exactamundo.....it's all about the results.

    For those interested in a BIT of serious action do not forget that that bit is a rebound after a continued period of serious investment degredation. Happens all the time. In the battery market we have seen plenty of canaries fall from their perch. The tough blighters make their way back. Once a BIT of the recent results were released we have the incredible action some of us have witnessed. But do not mistake that it has come from an incredibly low base. Hence more bags than an IGA supermarket. But what BOT is also about is actually the same - a results driven company.We are a trident at the moment, a triple split between acne, atopic dermatitis and psoriasis. Discount the antiseptic stuff even though it could be good.

    I like this approach to be honest and our situation could be something similar at the right time for a BIT of similar action.

    Until then we all wait patiently.

    But clearly some are not that patient. That's the market.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.010(2.78%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.0¢ 37.0¢ 33.5¢ $2.103M 6.050M

Buyers (Bids)

No. Vol. Price($)
2 32406 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 234417 5
View Market Depth
Last trade - 16.10pm 02/12/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.